Further analyses showed that dual-null genotype of GSTM1-GSTT1 had a significant higher association with lung cancer risk (OR = 1.29, 95% CI: 1.03 to 1.63, I2 = 61.7%, P = 0.011) (Table 5). This evidence concerns the gene GSTM1 and lung carcinoma.